+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 394 Pages
  • Global
From
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 77 Pages
  • Global
From
Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 53 Pages
  • Global
From
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 182 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Hypercalcemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Hypercalcemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • January 2025
  • 150 Pages
  • Global
From
Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • May 2024
  • 224 Pages
  • Global
From
Hemoglobinopathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region - Product Thumbnail Image

Hemoglobinopathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region

  • Report
  • March 2024
  • 131 Pages
  • Global
Eliquis Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Eliquis Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Thrombin Inhibitor Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Thrombin Inhibitor Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Hemoglobinopathies Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Hemoglobinopathies Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Myelofibrosis Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Myelofibrosis Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Antifibrinolytic Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Antifibrinolytic Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Epogen Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Epogen Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Fibrin Sealant Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Fibrin Sealant Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Beta-Thalassemia Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Beta-Thalassemia Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Polycythemia Vera Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Polycythemia Vera Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Coagulation Factor Deficiency Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Coagulation Factor Deficiency Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Tissue Plasminogen Activator Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Tissue Plasminogen Activator Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more